Co-Authors
This is a "connection" page, showing publications co-authored by JANICE BLALOCK and PAUL M CINCIRIPINI.
Connection Strength
6.322
-
Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912251.
Score: 0.688
-
Relationship of childhood trauma to depression and smoking outcomes in pregnant smokers. J Consult Clin Psychol. 2013 Oct; 81(5):821-30.
Score: 0.447
-
The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav. 2011 Dec; 25(4):652-63.
Score: 0.397
-
The Effect of Mood, Anxiety, and Alcohol Use Disorders on Smoking Cessation in Cancer Patients. J Cogn Psychother. 2011; 25(1):82-96.
Score: 0.377
-
Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav. 2008 Mar; 22(1):122-8.
Score: 0.310
-
Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict. 2006 Jul-Aug; 15(4):268-77.
Score: 0.276
-
Depression in pregnant women seeking smoking cessation treatment. Addict Behav. 2005 Jul; 30(6):1195-208.
Score: 0.250
-
Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial. Am J Psychiatry. 2024 Dec 11.
Score: 0.248
-
Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis. JAMA Oncol. 2024 Dec 01; 10(12):1689-1696.
Score: 0.248
-
Comparing the Fagerstr?m Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients. Nicotine Tob Res. 2024 Oct 22; 26(11):1576-1581.
Score: 0.246
-
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA. 2024 05 28; 331(20):1722-1731.
Score: 0.239
-
Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer. Cancer Prev Res (Phila). 2024 May 02; 17(5):217-225.
Score: 0.238
-
Brief report: Characterization of electronic cigarette use among patients of a comprehensive cancer center. Am J Addict. 2024 05; 33(3):339-342.
Score: 0.229
-
The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. JMIR Form Res. 2023 Jun 20; 7:e39487.
Score: 0.224
-
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440.
Score: 0.207
-
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241.
Score: 0.206
-
The importance of incorporating smoking cessation into lung cancer screening. Transl Lung Cancer Res. 2018 Jun; 7(3):272-280.
Score: 0.158
-
A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. Cogent Med. 2018; 5(1).
Score: 0.154
-
Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol. 2018 Feb; 38(1):34-41.
Score: 0.154
-
Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making. J Natl Compr Canc Netw. 2016 11; 14(11):1469-1477.
Score: 0.141
-
Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav. 2016 10; 61:32-9.
Score: 0.137
-
Selection of optimal tobacco cessation medication treatment in patients with cancer. Clin J Oncol Nurs. 2015 Apr; 19(2):170-5.
Score: 0.127
-
"Meaningful use" provides a meaningful opportunity. Cancer. 2014 Feb 15; 120(4):464-8.
Score: 0.115
-
Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res. 2013 Nov; 15(11):1807-15.
Score: 0.110
-
Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res. 2011 Aug; 13(8):699-705.
Score: 0.096
-
Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol. 2010 Feb; 78(1):44-54.
Score: 0.089
-
The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003 Apr; 71(2):292-301.
Score: 0.055
-
An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tob Control. 2000; 9 Suppl 3:III61-3.
Score: 0.044
-
Examination of the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Factor Structure in a Sample of Pregnant Smokers. Nicotine Tob Res. 2015 Jun; 17(6):653-60.
Score: 0.031
-
Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):336-43.
Score: 0.031
-
Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions. Am J Perinatol. 2015 Mar; 32(4):351-6.
Score: 0.030
-
The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet. 2010 Jan; 40(1):49-58.
Score: 0.022